Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.

Technology transfer from universities and other non-profit research institutions to private sector firms is core to the modern biopharma industry, but before the enactment of the Bayh-Dole Act in 1980

While Japan-based BioComo has been in existence for around a decade, it has so far concentrated on developing its academic research-derived platform technology based around TNFRSF signal activation, r

Device Transactions Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. ( See Exhibit 1. ) Late-stage venture capital rounds represented most of

Financings During the third quarter of 2015, start-up companies raised a total of $2.57 billion, $39 million less than last quarter. Biopharma companies pulled in an impressive $2.38 billion, 53% resu